HIV and fungal priority pathogens
Hatim Sati(World Health Organization), Nathan Ford(World Health Organization), Arnaldo Lopes Colombo(Universidade Federal de São Paulo), Tania C. Sorrell(The University of Sydney), Ana Alastruey‐Izquierdo(Instituto de Salud Carlos III), Arunaloke Chakrabarti(Dev Sanskriti Vishwavidyalaya), Felix Bongomin(University of Manchester), John R. Perfect(Duke University), Rita Oladele(University of Lagos), Retno Wahyuningsih(Universitas Kristen Indonesia), Tom Chiller(Norman Regional Health System), Nelesh P. Govender(University of Cape Town), Juan L. Rodrı́guez-Tudela(Instituto de Salud Carlos III), Chris Beyrer(Duke University)
Cited by 32
Related Papers
Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
|Clinical Infectious Diseases|2008|4.9k
Global and Multi-National Prevalence of Fungal Diseases—Estimate Precision
|Journal of Fungi|2017|2.9k
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
|Clinical Infectious Diseases|2019|2.8k
Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2010|2.7k
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
|New England Journal of Medicine|2007|1.8k